BIOSYNTHEMA
BioSynthema develops and researches pharamaceuticals for diagnostic and therapeutic applications. The product is a therapeutic agent for the treatment of neuroendocrine tumors. BioSynthema carries out both discovery research and product development for agents in clinical studies. The customer queries were answered through email, phone.
BIOSYNTHEMA
Industry:
Health Care Health Diagnostics Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.biosynthema.com
Total Employee:
11+
Status:
Active
Contact:
+1 314 615 6365
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Apache Bizland
Official Site Inspections
http://www.biosynthema.com
- Host name: 129.146.96.66.static.eigbox.net
- IP address: 66.96.146.129
- Location: Burlington United States
- Latitude: 42.509
- Longitude: -71.1984
- Metro Code: 506
- Timezone: America/New_York
- Postal: 01803
More informations about "BioSynthema"
BioSynthema
BioSynthema is currently developing compounds that will bring new and effective products to the market for the diagnosis and treatment of neuroendocrine tumors. New and Events. October 15, 2007 BioSynthema and Covidien Ltd. sign โฆSee details»
About Us - BioSynthema
About BioSynthema BioSynthema Inc. is located in Saint Louis, Missouri at The Center for Emerging Technologies Management. Jack Erion, Ph.D. President and CEO. Jack Erion is the โฆSee details»
BioSynthema - Crunchbase Company Profile & Funding
BioSynthema develops and researches pharamaceuticals for diagnostic and therapeutic applications. The product is a therapeutic agent for the treatment of neuroendocrine tumors. โฆSee details»
Biosynthema 2025 Company Profile: Valuation, Investors
Biosynthema General Information Description. Developer of unique pharmaceuticals intended to target cell surface receptors overexpressed in cancer cells. The company develops technology โฆSee details»
Investors - BioSynthema
BioSynthema Inc. is a privately held biotechnology company. The company carries out early stage discovery research, in addition to late stage development of promising lead compounds. Our โฆSee details»
Biosynthema, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Biosynthema, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Biosynthema Inc Company Profile, Financial and Strategic
Biosynthema, Inc. was founded in 2001 and is based in Saint Louis, Missouri. The company has an additional office in Amsterdam, the Netherlands. As of May 2010, Biosynthema, Inc. โฆSee details»
BioSynthema - Crunchbase
BioSynthema is a drug discovery and development company. Start Free Trial . Chrome ExtensionSee details»
Biosynthema, Inc.:Company Profile & Technical โฆ
Biosynthema, Inc. is a company that provides Medicine, Advanced Accelerator Applications, Dosimetry and more. Biosynthema, Inc. is headquartered in United States Missouri. โฆSee details»
BioSynthema - Tech Stack, Apps, Patents & Trademarks
Mar 10, 2025 BioSynthema is a drug discovery and development company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the โฆSee details»
BIOSYNTHEMA, INC. - Golden
BIOSYNTHEMA, INC. is a St. Louis-based company. Overview Structured Data Issues Contributors Activity. ContentsSee details»
COVIDIEN AND BIOSYNTHEMA SIGN EXCLUSIVE AGREEMENTS โฆ
๏ฌI am very encouraged that Covidien and BioSynthema have agreed to cooperate in the development and commercialization of this product,๏ฌ said Professor Krenning. ๏ฌThe โฆSee details»
BioSynthema Company Profile | Management and Employees List
Find contact information for BioSynthema. Learn about their Manufacturing market share, competitors, and BioSynthema's email format.See details»
BioSynthema - Overview, News & Similar companies - ZoomInfo
BioSynthema discovers and develops unique pharmaceuticals that are targeted to cell surface receptors overexpressed in cancer cells. The technology makes specific tumors highly visible โฆSee details»
Covidien, BioSynthema enter cancer therapy deal | AuntMinnie
Oct 18, 2007 Imaging firm Covidien and biopharmaceutical firm BioSynthema have signed exclusive agreements to develop and commercialize a nuclear medicine therapy for โฆSee details»
BioSynthema Inc. - insights.citeline.com
May 18, 2018 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
biosynthema.com - New and Events
BioSynthema is currently developing compounds that will bring new and effective products to the market for the diagnosis and treatment of neuroendocrine tumors. New and Events. October โฆSee details»
Technology - BioSynthema
Technology. BioSynthema specializes in receptor targeted peptides which have diagnostic and therapeutic applications. BioSynthema carries out research at its R&D laboratory in St. Louis, โฆSee details»
Biosynthema, Inc. (Biosynthema, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ โฆ
ไบ่งฃBiosynthema, Inc. (Biosynthema, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
News - BioSynthema
Jan 1, 2004 BioSynthema signs collaboration agreement with Demokritos National Centre for Scientific Research, and Erasmus Medical Centre to develop radiolabeled small molecules for โฆSee details»